The rationale behind the restrictions on the NIH ― put forward by the unofficial Department of Government Efficiency, once ...

Former U.S. Surgeon General Vivek Murthy released a January advisory to the public about the direct link between alcohol consumption and increased cancer risk. Now, work at the University ...

A conversation with the medical sociologist about her new book, Get It Out, and the perils of considering abortion, ...

Denise Schipani is a New York–based editor and writer with a special interest in health and healthcare. Her work has appeared in a wide range of consumer and custom magazines and websites. She's at ...

Julia Zumpano, RD, LD, has been a registered dietician at the Cleveland Clinic Center for Human Nutrition for almost 20 years ...

The European Union has banned a number of these food dyes and this is one of them. If they ban an item, it’s because they’ve done very rigorous testing and made a careful decision. They may base the ...

From the internet to the ozone layer, AI to the human genome, UC scientists have turned federal research funding into history ...

JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars ...

Genetics research reveals how diverse complex biological systems are. Diversity and collaboration make for more thorough and ...

Differentiating between a heart attack, cardiac arrest, and chest pain is crucial for timely intervention. A heart attack ...

Alex Lightly told Newsweek she used to hate her hair when she was younger, but has "learned to see the beauty" in her differences.

Capricor Therapeutics's dip caused by the CRL is a buying opportunity considering the readout of HOPE-3 within 2-3 months.